tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

REPL Stock Latest News

Replimune Group presents interim results from ARTACUS trial of RP1 monotherapy
The FlyReplimune Group presents interim results from ARTACUS trial of RP1 monotherapy
13d ago
REPL
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
PremiumPress Releases
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
13d ago
REPL
Replimune Group announces inducement grants under Nasdaq listing rule
PremiumThe Fly
Replimune Group announces inducement grants under Nasdaq listing rule
16d ago
REPL
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16d ago
REPL
Replimune Group Announces Major Executive Team Overhaul
PremiumCompany Announcements
Replimune Group Announces Major Executive Team Overhaul
25d ago
8K
REPL
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
PremiumPress ReleasesReplimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
25d ago
REPL
Replimune Group announces appointment of Patel to CEO, leadership transitions
PremiumThe Fly
Replimune Group announces appointment of Patel to CEO, leadership transitions
25d ago
REPL
Replimune Group price target raised to $12 from $10 at H.C. Wainwright
PremiumThe Fly
Replimune Group price target raised to $12 from $10 at H.C. Wainwright
2M ago
REPL
Replimune Group Is Worried About This – Should You Be Worried Too?
PremiumMarket News
Replimune Group Is Worried About This – Should You Be Worried Too?
2M ago
REPL
Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
2M ago
REPL
Replimune Group announce cash runway extended
PremiumThe Fly
Replimune Group announce cash runway extended
2M ago
REPL
Replimune Group reports Q3 EPS (77c), consensus (93c)
PremiumThe Fly
Replimune Group reports Q3 EPS (77c), consensus (93c)
2M ago
REPL
Disc Medicine appoints Franchi as CFO
PremiumThe FlyDisc Medicine appoints Franchi as CFO
2M ago
IRON
REPL
Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference
4M ago
REPL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
AKRO
HOTH
Replimune Group price target lowered by $38 at H.C. Wainwright, here’s why
PremiumThe Fly
Replimune Group price target lowered by $38 at H.C. Wainwright, here’s why
4M ago
REPL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
AKRO
ATHE
Replimune Group price target lowered to $14 from $70 at BMO Capital
PremiumThe Fly
Replimune Group price target lowered to $14 from $70 at BMO Capital
5M ago
REPL
Replimune Group price target lowered to $13 from $60 at BTIG
PremiumThe Fly
Replimune Group price target lowered to $13 from $60 at BTIG
5M ago
REPL
Replimune Group price target lowered by $37 at Barclays, here’s why
PremiumThe FlyReplimune Group price target lowered by $37 at Barclays, here’s why
5M ago
REPL
Replimune Group provides regulatory update on IGNYTE, data from ARTACUS trial
PremiumThe Fly
Replimune Group provides regulatory update on IGNYTE, data from ARTACUS trial
5M ago
REPL
Replimune Group announces CERPASS trial of CSCC did not meet primary endpoints
PremiumThe Fly
Replimune Group announces CERPASS trial of CSCC did not meet primary endpoints
5M ago
REPL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >